Tags: Drug.

Surinabant (SR147778) is a cannabinoid receptor type 1 antagonist developed by Sanofi-Aventis. It is being investigated as a potential treatment for nicotine addiction to assist smoking cessation.

Surinabant.png
ATC prefix
none
CAS number
288104-79-0
FDA UNII code
SF8R9VCB0X
IUPAC name
5-(4-bromophenyl)-1-(24-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide
PubChem
9849616

Loading...

This page contains content from the copyrighted Wikipedia article "Surinabant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.